Cargando…

What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population

The use and impact of complementary and alternative medicine (CAM) for anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) has not been reported. AAV patients seeking care at our center inquired about CAM, prompting a formal study. Study objectives were to discern how many AAV pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berg, Elisabeth A.B., McGregor, JulieAnne G., Burkart, Madelyn E., Poulton, Caroline J., Hu, Yichun, Falk, Ronald J., Hogan, Susan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295716/ https://www.ncbi.nlm.nih.gov/pubmed/25599078

Ejemplares similares

The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis
por: Agosto‐Burgos, Christian, et al.
Publicado: (2022)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

High Basal Activity of the PTPN22 Gain-of-Function Variant Blunts Leukocyte Responsiveness Negatively Affecting IL-10 Production in ANCA Vasculitis
por: Cao, Yali, et al.
Publicado: (2012)

Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
por: Chanouzas, Dimitrios, et al.
Publicado: (2019)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

Reactivity against Complementary Proteinase-3 Is Not Increased in Patients with PR3-ANCA-Associated Vasculitis
por: Tadema, Henko, et al.
Publicado: (2011)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)

The involvement of NETs in ANCA-associated vasculitis
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

ANCA Vasculitis Induction Management During the COVID-19 Pandemic
por: Salas, Antonio, et al.
Publicado: (2021)

Vasculitis Pathogenesis: Can We Talk About Precision Medicine?
por: Ozen, Seza, et al.
Publicado: (2018)

Everybody’s talking about equity, but is anyone really listening?: The case for better data-driven learning in health systems
por: Lee-Foon, Nakia K., et al.
Publicado: (2023)

Pathophysiology of ANCA-Associated Small Vessel Vasculitis
por: Kallenberg, Cees G. M.
Publicado: (2010)

Ocular disease in patients with ANCA-positive vasculitis
por: Watkins, Angela S., et al.
Publicado: (2009)

Levamisole-Induced ANCA Vasculitis and Cutaneous Necrosis
por: Tichauer, Matthew, et al.
Publicado: (2014)

Familial clusters of ANCA small-vessel vasculitis
por: Gomes, Ana Marta, et al.
Publicado: (2009)

Interstitial Lung Disease with ANCA-associated Vasculitis
por: Katsumata, Yasuhiro, et al.
Publicado: (2015)

Neutrophil Extracellular Traps in ANCA-Associated Vasculitis
por: Söderberg, Daniel, et al.
Publicado: (2016)

ANCA-associated vasculitis in childhood: recent advances
por: Calatroni, Marta, et al.
Publicado: (2017)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

Therapy of ocular complications in ANCA+ associated vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2021)

ANCA-associated vasculitis after COVID-19
por: Izci Duran, Tugba, et al.
Publicado: (2021)

B Lineage Cells in ANCA-Associated Vasculitis
por: Merino-Vico, Ana, et al.
Publicado: (2021)

ANCA Associated Vasculitis Subtypes: Response [Letter]
por: Merkel, Peter A, et al.
Publicado: (2022)

Manifestations of Covid-19-associated ANCA-vasculitis
por: Lishchuk-Yakymovych, Khrystyna, et al.
Publicado: (2023)

Daratumumab for the treatment of refractory ANCA-associated vasculitis
por: Ostendorf, Lennard, et al.
Publicado: (2023)

Vitamin D status in ANCA-associated vasculitis
por: Doubelt, Irena, et al.
Publicado: (2023)

Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity
por: Lardinois, Olivier M., et al.
Publicado: (2019)

Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation
por: Ohlsson, Sophie, et al.
Publicado: (2019)

Automated interpretation of ANCA patterns - a new approach in the serology of ANCA-associated vasculitis
por: Knütter, Ilka, et al.
Publicado: (2012)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tpmf29rbn9ck2ievhcpcrrokko